drugset / Trial / NCT03028571
Autonomic Blockade and Endogenous Glucose Production
RandomizedCrossoverSingle-blindBasic science
Summary
The investigators will test the null hypothesis that there will be no changes in the insulin-mediated suppression of endogenous glucose production (EGP) in response to autonomic blockade. To test this hypothesis, the investigators propose to determine the role of the autonomic nervous system in hepatic insulin resistance.
Timeline
- Start
- 2017-04-17
- Primary completion
- 2022-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trimethaphan | Small molecule | 4 mg | Intravenous |
Indications
No indication recorded.